Proapolipoprotein A1 demonstrates improved potential as a serum marker for brain metastases without vascular disease interference
April 1, 2009|Cleveland Clinic Journal of Medicine
Author and Disclosure Information
Vince Fazio
Cerebrovascular Research Center and Department of Cell Biology, Cleveland Clinic, Cleveland, OH
Peter Mazzone
Department of Pulmonary, Allergy, and Critical Care Medicine and Department of Hematology/Oncology, Cleveland Clinic, Cleveland, OH
Nicola Marchi
Cerebrovascular Research Center and Department of Cell Biology, Cleveland Clinic, Cleveland, OH
Thomas Masaryk
Department of Radiology, Cleveland Clinic, Cleveland, OH
Damir Janigro
Cerebrovascular Research Center and Department of Cell Biology, Cleveland Clinic, Cleveland, OH
